Advertisement

The Latest

Twenty-two percent of people who died of drug overdoses in 2022 had non-substance use related mental health disorders, according to an Aug. 29 analysis by HHS' Morbidity and Mortality Weekly Report. 

Spokane, Wash.-based Sacred Heart nurses, technicians, service and maintenance workers are planning to rally in protest of the hospital's plans to permanently close the inpatient child psychiatric unit, KXLY.com reported Sept. 4.

The Drug Enforcement Administration has increased the production limit of Vyvanse, an ADHD drug made by Takeda Pharmaceutical, and its generic versions by 24% to address an ongoing shortage of the medicines in the U.S. 

Individuals without previous mental health concerns taking weight loss medication semaglutide did not have a higher risk of depressive symptoms, suicidal thoughts or behaviors, a study published in JAMA Internal Medicine found. 

The National Institute of Health will fund a $20 million study following people with mental illness over five years. 

Advertisement